Key result
Trial protocol evaluates an adapted mindfulness program for reducing depressive symptoms and systolic blood pressure.
Why the study?
Community-based mental health interventions can reach underserved populations, and evaluating the effectiveness and implementation of a community-adapted mindfulness-based stress reduction program in Black/African American adults with comorbid depression and hypertension is needed.
Does an 8-week community-based adapted mindfulness-based stress reduction program improve depressive symptoms and systolic blood pressure in Black/African American adults with comorbid depression and hypertension?
Does an 8-week community-based adapted mindfulness-based stress reduction program improve depressive symptoms and systolic blood pressure in Black/African American adults with comorbid depression and hypertension?
This study protocol outlines a single-arm proof-of-concept trial to evaluate the preliminary effectiveness and implementation of a community-based mindfulness-based stress reduction intervention for improving depression and systolic blood pressure in Black/African American adults.
Supports community-adapted MBSR testing in Black adults with comorbid depression; leaves open effectiveness and implementation.
Background Community-based mental health interventions hold potential to reach communities who are less likely to engage in traditional clinic-based services. Partnering with community members and organizations to develop a community-informed approach increases the likelihood of successful implementation of these interventions. We will evaluate the effectiveness and implementation of an adapted mindfulness-based stress reduction intervention among Black/African American adults with comorbid depression and hypertension. Methods This trial is a single-arm, type 1 hybrid effectiveness-implementation study. We will recruit Black/African American adults (≥18 years) with elevated depressive symptoms (PHQ-9 scores ≥10) and a self-reported diagnosis of hypertension. All participants will be enrolled in an 8-week mindfulness-based stress reduction program that has been adapted for Black/African American adults, heart health, and community-based delivery. Study participants will complete surveys at baseline and at 4 weeks and 8 weeks post-baseline; blood pressure readings before and after the first and final mindfulness session; and a post-intervention focus group. We will also recruit community members to a community advisory board to advise on trial execution, challenges, implementation, and evaluation. Primary effectiveness outcomes include effect sizes of changes in depressive symptoms (Patient Health Questionnaire-9 scores) and systolic blood pressure from baseline to 8 weeks. The primary implementation outcome of implementation acceptability, appropriateness, feasibility will be assessed using mixed qualitative-quantitative methods. Discussion Successful completion of this trial will provide preliminary evidence for the effectiveness of mindfulness for improving depression and blood pressure control as well as the implementation of community-based mindfulness programs. Trial registration ClinicalTrials.gov (NCTXXXXXXXXX)
No takes yet. Share an insight, caveat, or question.
Carroll et al. (2026) studied Comorbid depression and hypertension. Adapted mindfulness-based stress reduction program (CALM-Chicago) was evaluated on Effect sizes of changes in depressive symptoms (PHQ-9 scores) and systolic blood pressure from baseline to 8 weeks, alongside implementation acceptability, appropriateness, and feasibility. An 8-week adapted mindfulness program (CALM-Chicago) is being evaluated in a single-arm trial protocol for changes in PHQ-9 scores and systolic blood pressure at 8 weeks; no results reported.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: